Preventive Medicine Doctors in Springfield, MA Accepting Medicare

5 Preventive Medicine doctors found. Showing 1 - 5

Richard A Stevens, M.D. Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 190 Fiberloid St Us Post, Assoc Area Medical Drive, Springfield, MA 01152 Phone: 413-785-6474

Benjamin J Bovell-ammon, MD, MPH Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Accepting Medicare Assignments Practice Location: 140 High St, Springfield, MA 01105 Phone: 413-794-2511    Fax: 413-794-8428

Randolph R Peto, M.D. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Baystate Medical Ctr, 759 Chestnut Street, Springfield, MA 01199 Phone: 413-794-4285

Stephen J Ryzewicz, MD Medicare: Accepting Medicare Assignments Practice Location: 759 Chestnut St, Springfield, MA 01107 Phone: 413-794-6297    Fax: 413-794-1767

Lisa N Anderson, M.D. Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 3400 Main St, 1st Floor, Springfield, MA 01199 Phone: 413-794-3726

News Archive

Study examines link between supply of primary care physicians and life expectancy

This study used U.S. population data to identify changes in the supply of primary care physicians across counties from 2005 to 2015 and the association with life expectancy and other outcomes.

EnVivo presents positive EVP-6124 Phase 2b trial data on schizophrenia at 50th ACNP meeting

EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, announced today that it is presenting the comprehensive analysis of a recently completed Phase 2b clinical trial of EVP-6124, a novel, orally bioavailable nicotinic alpha-7 agonist, in schizophrenia at the American College of Neuropsychopharmacology 50th Anniversary Annual Meeting.

Asian ministers review MDGs progress

South Asia is "lagging behind" in poverty and hunger reduction and is "in danger" of missing key Millennium Development Goal (MDG) targets, a U.N. official told Asian ministers gathered to discuss MDGs progress, Agence France-Presse reports. At the meeting, "senior officials told delegates from dozens of countries that global food, energy and financial crises in recent years had jeopardized progress toward achieving the goals set for 2015," the news service writes.

Ferring Pharmaceuticals announces publication of Phase 3 trials of LYSTEDA tablets for HMB

Ferring Pharmaceuticals Inc. today announced publication of one of its pivotal Phase 3 trials of LYSTEDA (tranexamic acid) tablets for cyclic heavy menstrual bleeding in the October issue of the peer-reviewed journal, Obstetrics & Gynecology. The six-month clinical trial demonstrated that LYSTEDA significantly reduced menstrual blood loss from baseline, and improved health-related quality-of-life parameters in women with cyclic HMB while maintaining safety and tolerability.

Read more Medical News

› Verified 6 days ago